Generation of pluripotent stem cells (iPSCs) from adult fibroblasts starts a “new era” in stem cell biology, as it overcomes several key issues associated with previous approaches, including the ethical concerns associated with human embryonic stem cells. However, as the genetic approach for cell reprogramming has already shown potential safety issues, a chemical approach may be a safer and easier alternative. Moreover, a chemical approach could be advantageous not only for the de-differentiation phase, but also for inducing reprogrammed cells into the desired cell type with higher efficiency than current methodologies. Finally, a chemical approach may be envisioned to activate resident adult stem cells to proliferate and regenerate damaged tissues in situ, without the need for exogenous cell injections.
Keywords: Stem cell, chemical molecules reprogramming stem cell, tissue regeneration, pluripotent stem cells (iPSCs), fibroblasts, embryonic stem cells, Parkinson's, Alzheimer, cardiopathies, Silicon Valley, regenerative medicine, retroviruses, lentiviruses, oncogenesis, polycistronic vectors, piggyBac, transposon system, episo-mal vectors, chemical approach, genetic manipulation approach, valproic acid, proliferation, pheno-types, 5-azacytidine, potent DNA methylation inhibitor, effective che-motherapeutic agent, myelogenous leukemia, cytokines, trans-differentiation, hepatocytes, dexamethasone, oligodendrocyte, astrocytes, polymerization, reversine, myoblasts, adipocytes, murine, neuroectodermal lineages, somatic cell nuclear transfer (SCNT), Aurora kinases, mes-enchymal stromal cells, diamino-pyrimidine, cyclosporin A (CSA), neural stem cells (NSCs), somatic cells
Rights & PermissionsPrintExport